Server:Oscar Platform 20180...
The main IP address: 96.45.83.39,Your server United States,Reston ISP:Tiggee LLC TLD:com CountryCode:US
The description :
cell division is an open access journal that allows the cell biology and cancer research communities to come together and focus on cross-sectional research related to cancer causation and it...
This report updates in 24-Jun-2018
Created Date: | 2005-04-25 |
Changed Date: | 2018-04-19 |
Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host celldiv.com. Currently, hosted in United States and its service provider is Tiggee LLC .
Latitude: | 38.938861846924 |
Longitude: | -77.34619140625 |
Country: | United States (US) |
City: | Reston |
Region: | Virginia |
ISP: | Tiggee LLC |
HTTP Header information is a part of HTTP protocol that a user's browser sends to called Oscar Platform 201802052158-170 containing the details of what the browser wants and will accept back from the web server.
Content-Length: | 18077 |
Expires: | 0 |
X-Forwarded-Host: | celldiv.biomedcentral.com |
Etag: | "fd23cc35d02b7fe2a6c2a11caa779676" |
X-Cache-Hits: | 0 |
X-Frame-Options: | DENY |
X-Served-By: | cache-jfk8148-JFK |
X-B3-Traceid: | 03e9629124c38ff7 |
X-B3-Spanid: | 55364e1b1ef2715d |
Date: | Sun, 24 Jun 2018 13:06:15 GMT |
Age: | 0, 0 |
X-Sn-Servicetimems: | 105 |
X-Xss-Protection: | 1; mode=block |
X-Cache: | MISS |
Accept-Ranges: | bytes, bytes |
Strict-Transport-Security: | max-age=31536000;includeSubDomains;preload |
Content-Md5: | /SPMNdArf+KmwqEcqneWdg== |
Connection: | keep-alive |
Server: | Oscar Platform 201802052158-170 |
Via: | 1.1 varnish |
X-Content-Type-Options: | nosniff |
Content-Encoding: | gzip |
X-Timer: | S1529845576.701539,VS0,VE206 |
Vary: | Accept-Encoding,Accept,x-oscar-cache-mode,x-springer-property-json,X-Frame-Options |
X-Vcap-Request-Id: | 08290aad-e39d-4964-6615-c834fa44366e, eef2be92-b255-4df7-6446-df182af578a1 |
Cache-Control: | private, must-revalidate |
Content-Type: | text/html; charset="UTF-8" |
soa: | ns10.dnsmadeeasy.com. dns.dnsmadeeasy.com. 2009010132 43200 3600 1209600 180 |
ns: | ns12.dnsmadeeasy.com. ns11.dnsmadeeasy.com. ns15.dnsmadeeasy.com. ns10.dnsmadeeasy.com. ns13.dnsmadeeasy.com. ns14.dnsmadeeasy.com. |
ipv4: | IP:96.45.83.39 ASN:16552 OWNER:TIGGEE - Tiggee LLC, US Country:US IP:96.45.82.109 ASN:16552 OWNER:TIGGEE - Tiggee LLC, US Country:US IP:96.45.83.224 ASN:16552 OWNER:TIGGEE - Tiggee LLC, US Country:US IP:96.45.82.248 ASN:16552 OWNER:TIGGEE - Tiggee LLC, US Country:US |
skip to content advertisement menu explore journals get published about bmc login my account search search all bmc articles search cell division menu home about articles submission guidelines search submit a manuscript copywrite hana paculová featured article: the emerging roles of cdk12 in tumorigenesis cyclin-dependent kinases (cdks) are key regulators of both cell cycle progression and transcription. in this review, we discuss current knowledge concerning the role of cdk12 in ovarian and breast tumorigenesis and the potential for chemical inhibitors of cdk12 in future cancer treatment. articles recent most accessed content type: research | 15 june 2018 imp/gtp balance modulates cytoophidium assembly and impdh activity authors: gerson dierley keppeke, chia chun chang, min peng, li-yu chen, wei-cheng lin, li-mei pai, luis eduardo coelho andrade, li-ying sung and ji-long liu content type: research | 24 may 2018 eg5 orchestrates porcine oocyte maturational progression by maintaining meiotic organelle arrangement authors: yan xie, minghui cheng, shan lu, qilong yuan, dongyu yang, ying chen, chen pan, yurong qiu and bo xiong content type: review | 20 march 2018 protein arginine methylation: an emerging regulator of the cell cycle authors: anita e. raposo and sabine c. piller content type: hypothesis | 20 february 2018 subunits of human condensins are potential therapeutic targets for cancers authors: hong-zhen wang, si-han yang, gui-ying li and xudong cao content type: commentary | 25 january 2018 phasing in on the cell cycle authors: steven boeynaems, peter tompa and ludo van den bosch most recent articles rss view all articles content type: review | 13 may 2010 an overview of cdk1-controlled targets and processes authors: jorrit m enserink and richard d kolodner content type: review | 3 october 2008 anti cancer effects of curcumin: cycle of life and death authors: gaurisankar sa and tanya das content type: methodology | 12 december 2011 live cell division dynamics monitoring in 3d large spheroid tumor models using light sheet microscopy authors: corinne lorenzo, céline frongia, raphaël jorand, jérôme fehrenbach, pierre weiss, amina maandhui, guillaume gay, bernard ducommun and valérie lobjois content type: review | 20 june 2013 to divide or not to divide: revisiting liver regeneration authors: yuichiro miyaoka and atsushi miyajima content type: review | 20 may 2015 aneuploidy and chromosomal instability in cancer: a jackpot to chaos authors: maybelline giam and giulia rancati most accessed articles rss view all articles aims and scope cell division is an open access, peer-reviewed journal, which publishes articles in areas including, but not limited to, molecular aspects of cell cycle control and cancer, cell growth, proliferation, survival, differentiation, signalling, gene transcription, protein synthesis, genome integrity, chromosome stability, centrosome duplication, dna damage and dna repair. read more editors-in-chief dr philipp kaldis, a*star, singapore dr robert duronio, university of north carolina, usa upcoming conferences for cell division 10th salk institute cell cycle meeting june 26-29, 2018 conrad t. prebys auditorium salk institute for biological studies in la jolla, california cold spring harbor laboratory meeting on mechanisms & models of cancer august 14-18, 2018 grace auditorium cold spring harbor laboratory, ny advertisement submit a manuscript editorial board sign up for article alerts and news from this journal follow follow us on twitter 2016 journal metrics speed 35 days from submission to first decision 33 days from acceptance to publication citation impact 3.909 - 2-year impact factor 2.500 - 5-year impact factor 0.721 - source normalized impact per paper (snip) 1.325 - scimago journal rank (sjr) usage 114,067 downloads 1160.5 usage factor social media impact 9 mentions more about our metrics advertisement cell division issn: 1747-1028 contact us submission enquiries: [email protected] general enquiries: [email protected] explore journals get published about bmc read more on our blogs receive bmc newsletters manage article alerts language editing for authors scientific editing for authors policies accessibility press center contact us leave feedback careers follow bmc bmc twitter page bmc facebook page bmc google plus page bmc weibo page by using this website, you agree to our terms and conditions , privacy statement and cookies policy. manage the cookies we use in the preference centre. © 2018 biomed central ltd unless otherwise stated. part of springer nature .
https://celldiv.biomedcentral.com/#main-content
https://celldiv.biomedcentral.com/articles/10.1186/s13008-018-0037-1
https://celldiv.biomedcentral.com/articles
https://celldiv.biomedcentral.com/articles/10.1186/s13008-018-0034-4
https://celldiv.biomedcentral.com/articles/10.1186/s13008-018-0036-2
https://celldiv.biomedcentral.com/articles/10.1186/1747-1028-8-8
http://celldiv.biomedcentral.com/about
https://celldiv.biomedcentral.com/articles/10.1186/s13008-018-0035-3
https://celldiv.biomedcentral.com/articles/most-accessed/rss.xml
https://celldiv.biomedcentral.com/#tab-2
https://celldiv.biomedcentral.com/articles/10.1186/s13008-017-0033-x
https://celldiv.biomedcentral.com/articles/10.1186/1747-1028-6-22
https://celldiv.biomedcentral.com/#tab-1
https://celldiv.biomedcentral.com/articles/10.1186/s13008-015-0009-7
https://celldiv.biomedcentral.com/submission-guidelines
Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;
Domain Name: CELLDIV.COM
Registry Domain ID: 152781491_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.eurodns.com
Registrar URL: http://www.EuroDNS.com
Updated Date: 2018-04-19T02:47:45Z
Creation Date: 2005-04-25T15:07:40Z
Registry Expiry Date: 2019-04-25T15:07:40Z
Registrar: EuroDNS S.A
Registrar IANA ID: 1052
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +352.27220150
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS10.DNSMADEEASY.COM
Name Server: NS11.DNSMADEEASY.COM
Name Server: NS12.DNSMADEEASY.COM
Name Server: NS13.DNSMADEEASY.COM
Name Server: NS14.DNSMADEEASY.COM
Name Server: NS15.DNSMADEEASY.COM
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-06-24T13:06:12Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
REGISTRAR EuroDNS S.A
SERVERS
SERVER com.whois-servers.net
ARGS domain =celldiv.com
PORT 43
TYPE domain
DOMAIN
NAME celldiv.com
CHANGED 2018-04-19
CREATED 2005-04-25
STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
NSERVER
NS10.DNSMADEEASY.COM 208.94.148.4
NS11.DNSMADEEASY.COM 208.80.124.4
NS12.DNSMADEEASY.COM 208.80.126.4
NS13.DNSMADEEASY.COM 208.80.125.4
NS14.DNSMADEEASY.COM 208.80.127.4
NS15.DNSMADEEASY.COM 208.94.149.4
REGISTERED yes
The following list shows you to spelling mistakes possible of the internet users for the website searched .